Announcements
- Enzo Biochem Reports Results of its Annual Meeting of Shareholders and Officer Appointments
- ENZO BIOCHEM REPORTS FIRST QUARTER FISCAL 2024 RESULTS AND PROVIDES BUSINESS UPDATE
- ENZO BIOCHEM REPORTS FOURTH QUARTER AND FISCAL YEAR 2023 RESULTS AND PROVIDES BUSINESS UPDATE
- Steven J. Pully Appointed to Enzo Biochem’s Board of Directors
- Enzo Biochem Announces Departure of Hamid Erfanian and Appointment of Kara Cannon as Interim CEO
- Enzo Biochem Completes Sale of Clinical Laboratory to Labcorp
More ▼
Key statistics
Short selling activityProvided by S&P Global Market Intelligence
Open | 3.12 |
---|---|
High | 3.12 |
Low | 3.12 |
Bid | 3.02 |
Offer | 3.04 |
Previous close | 3.12 |
Average volume | -- |
---|---|
Shares outstanding | 51.23m |
Free float | 38.60m |
P/E (TTM) | -- |
Market cap | 59.42m USD |
EPS (TTM) | -0.3516 USD |
Data delayed at least 15 minutes, as of Jun 10 2021.
More ▼